Michael Bromberg, MD, PhD, Chief of the Section of Hematology at Temple University Hospital, provided perspective for a HealthCentral article on IVIG, or intravenous immunoglobulin, for the treatment of ITP (immune thrombocytopenic purpura). ITP is an autoimmune disease that leads to low levels of platelets in your blood, which are cells that help with blood clotting.
Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.
Learn More
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH